Dr. Powers is a physician/investigator on faculty as a Professor of Clinical Medicine at the George Washington University School of Medicine. Prior to his current position Dr. Powers was the Lead Medical Officer for Antimicrobial Drug Development and Resistance Initiatives in the Office of Antimicrobial Products, Center for Drug Evaluation and Research, at the US Food and Drug Administration where he was responsible for issues related to clinical trials and policy in antimicrobial research. Dr Powers also worked in the Office of Medical Policy during his time at FDA. Dr. Powers was a co-chair for the Inter-Agency Task for on Antimicrobial Resistance of 11 federal agencies responsible for implementing the Public Health Action Plan to Combat Antimicrobial Resistance, and a member of the WHO Advisory Group on Integrate Surveillance of Antimicrobial Resistance. Prior to joining the FDA, Dr. Powers was assistant professor in the Division of Infectious Diseases at the University of Maryland School of Medicine and he still is on the faculty. Dr. Powers research is in the development and evaluation of patient-centric outcomes for clinical trials and advancing research methodologies in general. Dr. Powers also actively sees patients and attends on the infectious diseases service.